European Parliament opposes authorization of genetically modified maize MON 94804

The European Parliament has adopted a position on the authorization of genetically modified maize MON 94804. This decision comes in a context where the European Commission wants to allow the marketing of this product. The adopted text expresses concerns about safety for human health, animal health and the environment.

Context and objectives

The legal basis is Regulation (EC) No 1829/2003 on genetically modified food and feed. The main objective is to ensure a high level of protection for health and the environment, in accordance with the precautionary principle. The authorization procedure involves EFSA assessment and consultation with Member States.

Key measures

• Parliament considers the Commission's draft decision exceeds implementing powers
• Requests withdrawal of the authorization draft decision
• The authorization application was submitted by company Bayer in February 2023
• EFSA issued a favorable opinion in March 2024
• The Standing Committee did not adopt a clear position in September 2024
• There are concerns about the effects of artificial micro RNA on health

Timeline and implementation

The authorization process is ongoing. The European Commission must take into account Parliament's position. If the draft decision is not withdrawn, legislative procedures may continue. Implementation of any authorization would be monitored by national and European authorities.

Impact for citizens and stakeholders

European citizens benefit from protection against potential GMO risks. Food producers and distributors must comply with strict regulations. Farmers using feed could be affected by the final decision. Consumers have the right to information about the presence of GMOs in food products.